Bálint Kónya

Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition

David Goyard, Bálint Kónya, Aikaterini S. Chajistamatiou et al. · European Journal of Medicinal Chemistry · 2015 · 83 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +16

Glycogen Phosphorylase Inhibitor N-(3,5-Dimethyl-Benzoyl)-N’-(β-D-Glucopyranosyl)Urea Improves Glucose Tolerance under Normoglycemic and Diabetic Conditions and Rearranges Hepatic Metabolism

Lilla Nagy, Tibor Docsa, Magdolna Szántó et al. · PLoS ONE · 2013 · 46 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

Synthesis of heterocyclic N-(β-d-glucopyranosyl)carboxamides for inhibition of glycogen phosphorylase

Bálint Kónya, Tibor Docsa, Pál Gergely et al. · Carbohydrate Research · 2012 · 26 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +10

Assessment of synthetic methods for the preparation of N-β-d-glucopyranosyl-N′-substituted ureas, -thioureas and related compounds

László Somsák, Nóra Felföldi, Bálint Kónya et al. · Carbohydrate Research · 2008 · 22 citations

Pharmacy, Biochemistry, Medicinal Chemistry +3

Tethered derivatives of d-glucose and pentacyclic triterpenes for homo/heterobivalent inhibition of glycogen phosphorylase

Keguang Cheng, Jun Liu, Hongbin Sun et al. · New Journal of Chemistry · 2010 · 22 citations

Natural Sciences, Biochemistry, Chemistry +17